Clinical Trial Update: Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adjusting clopidogrel dose based on platelet reactivity monitoring improves outcomes in patients with high on-treatment platele…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Acute Coronary Syndromes | Phase 3 | Status: COMPLETED